Status:
COMPLETED
Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)
Lead Sponsor:
Organon and Co
Conditions:
Osteoarthritis
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of etoricoxib in the treatment of osteoarthritis of the knee.
Eligibility Criteria
Inclusion
- At least 40 years of age with a clinical diagnosis of Osteoarthritis (OA)of the knee for 6 months prior to study entry (ARA class I, II, or III).
- Positive therapeutic effect from prior NSAID therapy.
- Worsening of symptoms upon withdrawal of prior treatment.
- With the exception of OA, in otherwise good health
Exclusion
- Weight no more than 280 pounds (male or female).
- Recent, sustained use of gastroprotective agents.
- History of arthroscopy of the affected knee within 6 months prior to study entry.
- History of acute ligamentous or meniscal injury of the study joint within the previous 2 years.
Key Trial Info
Start Date :
June 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2002
Estimated Enrollment :
1167 Patients enrolled
Trial Details
Trial ID
NCT00242489
Start Date
June 1 1998
End Date
July 1 2002
Last Update
February 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.